New option listings for July 30th include Perspective Therapeutics Inc (CATX), Dusa Pharmaceuticals (DUSA), FEDERATED HERMES ETF TRUST US STRATEGIC DIV (FDV), and ONESTREAM, INC. CLASS A (OS).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Perspective Therapeutics to Participate at Upcoming Investor Conferences in August
- Perspective Therapeutics initiated with a Buy at BofA
- Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results
- Perspective Therapeutics price target raised to $19 from $2 at Oppenheimer
- Perspective Therapeutics CEO buys $117.4K in common stock
